PJ34 hydrochloride, a potential miracle tumor suppressing compound
2D and 3D images of PJ34 hydrochloride
Images: PubChem
PJ34 hydrochloride is emerging as a highly effective treatment for pancreatic cancer. It had previously proven to enhance effects of certain liver cancer treatments - but now it has come into a powerful position of its own by demonstrating remarkable potential in treatment of pancreatic cancer, with up to 90% reduction in size of tumors comprised of human cancer cells and placed into mice achieved in the course of under two months.
Pancreatic cancer is one of the most severe kinds of cancer. Usually undiscovered until Stage 3 or even Stage 4, it has for a long time been a problem that tended to be but a death sentence by the time those afflicted learned the truth of their condition. This discovery may bring a sea change to their situation.
Given the dire situation those suffering from pancreatic cancer find themselves in, one can only hope this discovery proceeds from the lab to clinical trials and then, if all goes well, to wide scale use as expeditiously as possible. There are patients out there waiting for a solution like this - all the while they have little to use and only years of their lives to gain.
Source
Israeli Study Finds Molecule Triggers Self-Destruction Of Pancreatic Cancer Cells
NoCamels, 3 December 2019
PJ34 hydrochloride
PubChem
PJ34, an inhibitor of PARP-1, suppresses cell growth and enhances the suppressive effects of cisplatin in liver cancer cells
Sheng-Hui Huang, Min Xiong Xiao-Ping, Chen Zhen-Yu Xiao, Yin-Feng Zhao and Zhi-Yong Huang, Oncology Reports, 1 September 2008
PJ34 triggers self-destruction of human pancreatic cancer cells
Hannah Balfour, Drug Target Review, 3 December 2019